Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacovigilance Signal Management

Posted on By

SOP for Pharmacovigilance Signal Management

Guidelines for Managing Pharmacovigilance Signals

1) Purpose

The purpose of this SOP is to outline the procedures for managing pharmacovigilance signals, including their identification, evaluation, prioritization, and documentation, to ensure timely and appropriate action is taken.

2) Scope

This SOP applies to all pharmacovigilance personnel involved in the signal management process, including those responsible for signal detection, evaluation, and communication.

3) Responsibilities

The Signal Management Team is responsible for handling all aspects of signal management. The Pharmacovigilance (PV) Manager oversees the process to ensure compliance with regulatory requirements and internal policies.

See also  SOP for Pharmacovigilance Data Privacy and Confidentiality

4) Procedure

4.1 Signal Detection

  1. Collect data from various sources, including spontaneous reports, clinical studies, and literature.
  2. Use statistical tools and manual review to detect potential signals.
  3. Document detected signals in the signal management system.

4.2 Signal Evaluation

  1. Assess the clinical significance and potential impact of detected signals.
  2. Review relevant medical literature and additional data to support the evaluation.
  3. Determine the need for further investigation or immediate action based on the evaluation.

4.3 Signal Prioritization

  1. Prioritize signals based on their potential impact on patient safety and regulatory requirements.
  2. Assign a risk level to each signal (e.g., high, medium, low) based on evaluation findings.
  3. Develop a timeline for addressing each signal based on its priority level.
See also  SOP for Pharmacovigilance Signal Evaluation

4.4 Signal Action Plan

  1. Develop action plans for each prioritized signal, including investigation steps, regulatory reporting, and communication strategies.
  2. Assign responsibilities for each action item to appropriate team members.
  3. Monitor the implementation of action plans and update them as necessary.

4.5 Documentation and Reporting

  1. Maintain detailed records of all signal detection, evaluation, prioritization, and action activities.
  2. Prepare periodic reports on signal management activities for internal review and regulatory submission.
  3. Ensure all documentation is stored securely and is easily accessible for audits and inspections.

4.6 Communication

  1. Communicate significant signals and actions to relevant internal and external stakeholders, including regulatory authorities.
  2. Conduct regular signal review meetings with the PV team and other relevant departments.
  3. Provide training and updates on signal management procedures to all relevant staff.
See also  SOP for Pharmacovigilance Training Program

5) Abbreviations, if any

PV – Pharmacovigilance

6) Documents, if any

Signal detection records, evaluation reports, prioritization logs, action plans, communication logs.

7) Reference, if any

ICH E2E Pharmacovigilance Planning, EU Good Pharmacovigilance Practices (GVP) Module IX.

8) SOP Version

Version 1.0

Pharmacovigilance Tags:Pharmacovigilance adverse event reporting SOP, Pharmacovigilance audit preparation SOP, Pharmacovigilance case processing SOP, Pharmacovigilance compliance monitoring SOP, Pharmacovigilance compliance SOP, Pharmacovigilance data collection SOP, Pharmacovigilance data privacy SOP, Pharmacovigilance database management SOP, Pharmacovigilance documentation management SOP, Pharmacovigilance guidelines, Pharmacovigilance literature review SOP, Pharmacovigilance medical review SOP, Pharmacovigilance periodic reporting SOP, Pharmacovigilance procedure document, Pharmacovigilance quality management SOP, Pharmacovigilance regulatory reporting SOP, Pharmacovigilance risk assessment SOP, Pharmacovigilance risk management plan SOP, Pharmacovigilance risk minimization SOP, Pharmacovigilance safety reporting SOP, Pharmacovigilance signal detection SOP, Pharmacovigilance signal management SOP, Pharmacovigilance SOP template, Pharmacovigilance system master file SOP, Pharmacovigilance training program SOP

Post navigation

Previous Post: SOP for Analytical Method Development for Aerosols
Next Post: SOP for Formulation Development Scale-Up Studies

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version